跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,150 条关于
“miR-342”
全部
5,150
临床试验
3,617
药物
926
机构
99
资讯
508
28天前
Australian researchers uncover molecular switch driving triple-negative breast cancer metastasis, pointing to CDK4/6 inhibitor repurposing
去年
CSF Biomarkers NfL, CHIT1, and miR-181b Evaluated for ALS Diagnosis and Prognosis
去年
HDAC Inhibition in Muscle Cells Enhances Bone Regeneration via Extracellular Vesicles
去年
Sanofi Invests in Resalis Therapeutics' miRNA-22 Inhibitor for Obesity Treatment
上个月
Novel miRNA-129–Based Therapy Achieves Over 95% Tumor Shrinkage in Preclinical NSCLC Model, Halting Drug Resistance
去年
NeuroSense's PrimeC Shows 33% Reduction in ALS Disease Progression in Phase 2b Trial
去年
ARTHEx Biotech Secures $87M Series B to Advance Novel RNA Therapy for Myotonic Dystrophy Type 1
去年
Epigenetic Drug Development Sees Record $342M Series A Funding Surge in Early 2024
6个月前
ARTHEx Biotech Receives FDA Fast Track Designation for ATX-01 in Myotonic Dystrophy Type 1
6年前
Overcoming Osimertinib Resistance in EGFR-Mutant NSCLC Through GSK-3 Inhibition
第 1 页,共 51 页
上一页
下一页